Naftifine Completed Phase 3 Trials for Tinea Pedis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00750139Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Pedis
NCT02633813BE Study of Naftifine HCL
NCT01289015Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis
NCT01290341Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis